Summary
Cencora, Inc. (formerly AmerisourceBergen Corporation) filed an 8-K on November 16, 2022, to announce a significant addition to its Board of Directors. Effective January 1, 2023, Dr. Redonda G. Miller will join the Board. Dr. Miller brings extensive experience from her role as president of The Johns Hopkins Hospital and her prior positions within the Johns Hopkins Health System. Her appointment is seen as a strategic move to enhance the Board's expertise, particularly in healthcare operations and leadership. This filing also outlines the compensation structure for Dr. Miller as a non-employee director, which includes an annual cash retainer of $100,000 and an annual equity award valued at $200,000 at the time of grant. The Board has confirmed Dr. Miller's independence according to NYSE standards. No related-party transactions requiring disclosure were noted. This strategic board expansion signals the company's ongoing commitment to strong governance and leveraging specialized leadership to navigate the evolving healthcare landscape.
Key Highlights
- 1Dr. Redonda G. Miller elected to the Board of Directors, effective January 1, 2023.
- 2Dr. Miller brings significant healthcare leadership experience as President of The Johns Hopkins Hospital.
- 3The Board determined Dr. Miller meets independence standards set by the NYSE.
- 4Compensation for Dr. Miller as a non-employee director includes a $100,000 annual cash retainer and $200,000 in annual equity awards.
- 5No related-party transactions between Dr. Miller and the Company require disclosure.
- 6The news of Dr. Miller's appointment was also disseminated via a press release on November 16, 2022.